FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is the new chemical compound - a 3-(2,2,2-trimethylhydrazinium)propionate derivative - 3-(2,2,2-trimethylhydrazinium)potassium propionate glycinate, (CH3)3N+NHCH2CH2COOKRCOO-, wherein exhibiting endothelioprotective activity. The presented derivative can find application in medicine in the integrated treatment for endothelial dysfunction correction in cardiovascular diseases.
EFFECT: enhanced endothelioprotective properties as compared with previously known mildronat due to the introduction of new functional group showing the most manifested antioxidant properties.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-BROMNICOTINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467745C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE -3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE NICOTINATE DERIVATIVE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2465268C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-NICOTINATE HYDROXIDE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467744C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - POTASSIUM GLYCINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE | 2011 |
|
RU2457198C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-NICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458054C1 |
METHOD OF TADALAFIL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364395C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-BROMNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458690C1 |
METHOD FOR CORRECTING ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF INDAPAMIDE AND RESVERATROL AT L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2302241C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-NICOTINATE HYDROXIDE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2457202C1 |
METHOD OF PICAMILONUM-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364393C1 |
Authors
Dates
2012-11-27—Published
2011-08-08—Filed